Searched for
INTRANASAL COVID VACCINE
3 lakh doses of intranasal Covid vaccine sent to hospitals: Bharat Biotech's Krishna EllaHe was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madiso...- First Indian intranasal Covid vaccine to be launched on Jan 26"Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella s...
- Govt may not procure Bharat Biotech's intranasal Covid vaccine iNNOVACCBharat Biotech has made its intranasal Covid-19 vaccine iNNOVACC available on CoWin, priced at ₹800 per dose for private markets and ₹325 f...
- What you need to know about getting Bharat Biotech's nasal vaccine iNCOVACCBharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....
- Covid Nasal Vaccine: Here is how to book an appointment for a booster dose on CoWINThe Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccine, iNCOVACC, for use as a booster dose. The vaccine is avail...
- India plans to make COVID-19 negative test mandatory for passengers from high caseload countriesWith Covid emerging as a renewed threat around the world, India is ramping up efforts to prevent another wave in the country, including res...
- Bharat Biotech's intranasal Covid vaccine approved, to be available on CO-WIN from FridayBharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a bo...
- Everything you need to know about India’s 1st intranasal Covid vaccineThe DCGI has approved Bharat Biotech's first intranasal Covid vaccine BBV154 for primary vaccination against the infection for those over t...
- Bharat Biotech seeks DCGI nod for phase-3 study of intranasal Covid vaccine in 5-18 age groupiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candid...
- BBV154: What you need to know about Bharat Biotech's nasal Covid vaccineIt may produce local antibodies in the upper respiratory tract - which could provide the potential to reduce infection and transmission.
- Bharat Biotech seeks nod for intranasal Covid vaccineAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- NTAGI may soon review efficacy data of India's first intranasal Covid vaccineThe date of the meeting is yet to be fixed. India's drug controller had in January this year given permission to Bharat Biotech to conduct ...
- DCGI allows Bharat Biotech to conduct phase-3 trials for Covid's intranasal booster doseThe trials of the Intranasal vaccine will take place at nine different sites of the country.
- Bharat Biotech gets nod for Phase 2/3 trials of intranasal Covid vaccineBBV154 is the first intranasal Covid-19 vaccine to undergo human trials in India. It has now received approval to conduct Phase 2 randomise...
- Intranasal COVID vaccine candidate in early clinical stage of development in India: GovtMost vaccines are administered by injection through intramuscular or subcutaneous route.
Load More
